Becton Dickinson

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.

BD expanded smart connected care solutions portfolio by acquiring the Critical Care product group from Edwards Lifesciences in 2024, now known as Advanced Patient Monitoring (APM), a business unit within Connected Care segment. As pioneers in the field of advanced hemodynamics, APM has a rich history of creating hemodynamic monitoring solutions that have transformed patient care over more than 50 years. Our AI-powered solutions and smart monitoring technology provide real-time data and insights, enhancing decision-making across various clinical scenarios. As we pursue our Purpose of advancing the world of health™, we collaborate closely with clinicians to develop innovative technologies and comprehensive clinical education for the advanced monitoring of patients. Every day, we partner with our customers to help them stay ahead of critical moments. Our extensive portfolio of products addresses the diverse needs of healthcare professionals, empowering them to deliver exceptional care.

For more information on BD, please visit www.bd.com

Encare

Encare helps you implement ERAS® (Enhanced Recovery After Surgery) through our collaboration with ERAS® Society by:

Providing the interactive and digital platform, the ERAS® Interactive Audit System (EIAS), for evidence-based best practice management at your hospital
Providing training to you and other healthcare professionals through the ERAS® Implementation Program (EIP)

For more information, please visit www.encare.net

Fresenius Kabi

As a global healthcare company, Fresenius Kabi is Committed to Life. The company's products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With more than 43,000 employees and present in over 100 countries, Fresenius Kabi's expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies.

Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of almost 450 million patients annually. With Vision 2026, as part of the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare.

For more information, please visit www.fresenius-kabi.com/sg

InBody

In the early 1990s, InBody founder and CEO Dr. Kichul Cha identified significant limitations in existing bioelectrical impedance analysis (BIA) devices, which lacked the accuracy and medical reliability required for meaningful clinical use. Leveraging his background in mechanical engineering, Dr. Cha set out to develop a more precise and scientifically sound solution. InBody was founded in 1996, and the first InBody device was introduced two years later. Since then, InBody has evolved from a small biotechnology startup in South Korea into a global company, with branches and distributors in over 80 countries worldwide. Today, healthcare professionals trust InBody for its precise, accurate, and reproducible body composition data, delivered through a user-friendly and efficient system.

The InBody BWA 2.0S and InBody S10 utilize advanced electrode technology to assess body composition, detect excess fluid, and evaluate cellular health. Both models support measurements in standing, sitting, and supine positions, making them suitable for bedridden, immobile, or amputee patients. As a result, these devices are widely recognized and utilized across multiple clinical settings, including nephrology, cardiology, and intensive care units (ICU), for accurate assessment of body composition and body water status.

For more information, please visit www.inbodyasia.com

Nestle

Nestlé Health Science empowers healthier lives through nutrition

As a global leader in the science of nutrition, we nourish those who need extra care, fill nutrition gaps and provide innovative products for healthier future, enabling patients to live their healthier lives. The right nutrition can be life-changing, and we have developed our nutrition portfolio around this belief.

We offer an extensive range of nutritional solutions including metabolic health, healthy ageing, gut health, critical care and oncology. The wide range of solutions we offer across the spectrum of life has one common denominator: science-based products that help people live their best lives. Through extensive research and development, working with healthcare providers and focusing on innovation, we are bringing the best options for individual needs and the latest advances in nutrition to the world. The best results can only come from the best science, and our dedication is unwavering.

You'll find our products in more than 140 countries, brought to you by a team of more than 12,000 employees worldwide dedicated to the power of nutrition. We make our products with sustainability in mind. In 2020, all our factories reduced their landfill waste to zero, and over the last decade we have made big reductions to our greenhouse gas emissions and water usage.

For more information, please visit www.nestlehealthscience.sg

Pharmacosmos

Pharmacosmos A/S is a global leader in carbohydrate chemistry and innovative treatments for iron deficiency and iron deficiency anaemia. Building on our foundational expertise in carbohydrate chemistry and cell cycle biology, we develop innovative treatments for unmet patient needs, with a focus on iron metabolism and blood-related disorders. Founded in 1965 and headquartered in Denmark, our team is made up of more than 700 specialists across the UK, Ireland, the Nordics, Germany, Canada, the USA, and China.

Our ambition is to become the world's preferred partner in the management of iron deficiency and iron deficiency anaemia. We strive to achieve this partnership by simplifying the treatment, spearheading the improvement of patient safety, and driving the expanded use of high-dose intravenous iron across therapy fields.

For more information, please visit www.pharmacosmos.com

Solventum

3M Health Care is now Solventum

At Solventum, we enable better, smarter, safer healthcare to improve lives. As a new company with a long legacy of creating breakthrough solutions for our customers' toughest challenges, we pioneer game-changing innovations at the intersection of health, material and data science that change patients' lives for the better while enabling healthcare professionals to perform at their best. Because people, and their wellbeing, are at the heart of every scientific advancement we pursue. We partner closely with the brightest minds in healthcare to ensure that every solution we create melds the latest technology with compassion and empathy. Because at Solventum, we never stop solving for you.

For more information, please visit www.solventum.com